GSA CAPITAL PARTNERS LLP

Position in FBIO — Fortress Biotech, Inc.

CIK 1362033 LONDON, X0

Position in FBIO

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,402,924

+$693,891 QoQ

Shares Held

458,472

+80.4% QoQ

Ownership

1.25%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

of 55 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. FBIO ranks #20 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IOVA	Iovance Biotherapeutics, Inc.	655,318	$2,726,122
2	IMVT	Immunovant, Inc.	65,267	$2,514,737
3	GOSS	Gossamer Bio, Inc.	187,337	$2,472,846
4	AXSM	Axsome Therapeutics, Inc.	9,419	$2,305,488
5	CABA	Cabaletta Bio, Inc.	668,563	$2,079,230
6	MLTX	MoonLake Immunotherapeutics	106,695	$2,077,351
7	ATYR	aTYR PHARMA INC	3,454,863	$2,062,553
8	CORT	Corcept Therapeutics Inc	23,257	$2,022,196

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,402,924	458,472	+80.4%	Shares	Sole	2026-08-06
2026-03-31	$709,033	254,134	+604.5%	Shares	Sole	2026-05-08
2025-12-31	$132,030	36,074	-40.3%	Shares	Sole	2026-02-06
2024-12-31	$122,762	60,474	-26.0%	Shares	Sole	2025-02-07
2024-09-30	$118,572	81,774	-58.1%	Shares	Sole	2024-11-05
2024-06-30	$333,927	195,279	+82.0%	Shares	Sole	2024-08-15
2024-03-31	$214,552	107,276	-47.3%	Shares	Sole	2024-05-03
2022-03-31	$276,912	203,612	+8.8%	Shares	Sole	2022-05-11
2021-09-30	$602,713	187,178	+23.1%	Shares	Sole	2021-11-12
2021-06-30	$542,857	152,061	+116.5%	Shares	Sole	2021-08-05
2021-03-31	$247,968	70,246	+206.4%	Shares	Sole	2021-05-10
2020-12-31	$72,681	22,928	—	Shares	Sole	2021-02-03
No filing history on record for this holder in this stock.